SuperworthNovoCure shares outstanding NVCR
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 116M
- On a year earlier
- +4.0%
- more shares
NovoCure had 116M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 4.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 112.1M | +4% |
| FY2024 | 108.3M | +1% |
| FY2023 | 106.9M | +2% |
| FY2022 | 105M | +1% |
| FY2021 | 103.9M | −6% |
| FY2020 | 110.6M | +2% |
| FY2019 | 107.9M | +16% |
| FY2018 | 93.1M | +4% |
| FY2017 | 89.4M | +3% |
| FY2016 | 86.8M | +4% |
| FY2015 | 83.6M | +552% |
| FY2014 | 12.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 116M | +4% | |
| Q1 FY26 | 114.1M | +4% | |
| Q4 FY25 | 112.1M | +4% | |
| Q3 FY25 | 111.9M | +3% | |
| Q2 FY25 | 111.6M | +4% | |
| Q1 FY25 | 110.3M | +3% | |
| Q4 FY24 | 108.3M | +1% | |
| Q3 FY24 | 108.2M | +1% | |
| Q2 FY24 | 107.7M | +1% | |
| Q1 FY24 | 107.3M | +2% | |
| Q4 FY23 | 106.9M | +2% | |
| Q3 FY23 | 106.8M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on NovoCure
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.